Advertisement
Canada markets close in 5 hours 31 minutes
  • S&P/TSX

    21,950.19
    +64.81 (+0.30%)
     
  • S&P 500

    5,099.07
    +50.65 (+1.00%)
     
  • DOW

    38,266.44
    +180.64 (+0.47%)
     
  • CAD/USD

    0.7321
    -0.0003 (-0.04%)
     
  • CRUDE OIL

    84.01
    +0.44 (+0.53%)
     
  • Bitcoin CAD

    88,121.73
    +973.59 (+1.12%)
     
  • CMC Crypto 200

    1,340.74
    -55.79 (-4.00%)
     
  • GOLD FUTURES

    2,353.00
    +10.50 (+0.45%)
     
  • RUSSELL 2000

    2,003.10
    +21.98 (+1.11%)
     
  • 10-Yr Bond

    4.6510
    -0.0550 (-1.17%)
     
  • NASDAQ

    15,900.96
    +289.20 (+1.85%)
     
  • VOLATILITY

    15.22
    -0.15 (-0.98%)
     
  • FTSE

    8,137.52
    +58.66 (+0.73%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6841
    +0.0020 (+0.29%)
     

Teva Pharmaceutical’s Performance in 4Q17 and 2017

Teva Pharmaceutical’s Performance in 4Q17 and 2017

In 4Q17, Teva Pharmaceutical Industries (TEVA) reported revenues of $5.5 billion compared to $6.5 billion in 4Q16. That’s a 16% growth on a YoY (year-over-year) basis and a 3% growth on a quarter-over-quarter basis.